Caricamento...
History of cardiovascular events and cardiovascular risk factors among patients initiating strontium ranelate for treatment of osteoporosis
PURPOSE: To estimate the proportion of osteoporosis patients in whom initiating strontium ranelate treatment, under new EMA guidelines, should be contraindicated because of a history of cardiovascular events or risk for cardiovascular events. MATERIALS AND METHODS: This was a retrospective analysis...
Salvato in:
| Pubblicato in: | Int J Womens Health |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4655964/ https://ncbi.nlm.nih.gov/pubmed/26604831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJWH.S88627 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|